How to Tell If Your Problem Is Strategy or Just Execution

In 2003, Lego's own numbers told a story its leadership didn't want to read. A pre-tax loss on the order of DKK 1.4 billion, with global sales down roughly a quarter from the year before⁵ - the worst year in the company's history, arriving not despite ambition but because of it.¹ The toymaker had spent the previous half-decade doing everything a growth-hungry board tells you to do: it opened theme parks, launched a clothing line, shipped video games, and let its catalog of unique plastic pieces balloon toward 14,200 distinct parts.³ Every one of those moves had a business case attached when it was approved. None of them turned out to be the actual problem - and neither, it turned out, was a lack of trying hard enough at any of them. The plan itself was the failure. And the instinct of a company in that position is almost never to ask whether the plan is wrong. It's to execute the wrong plan with more urgency.

The fork every turnaround hits: a bad plan and a good plan run badly produce the same quarter

Every declining company arrives at some version of this fork, whether anyone in the room names it or not: is the plan wrong, or is a good plan just being run badly? The two failures look identical from the outside - falling revenue, missed targets, a board demanding answers - but they call for opposite responses. If the plan is broken, better execution just gets the company to the wrong destination faster. If the execution is broken, tearing up the plan throws away a strategy that would have worked fine with a more competent team behind it. Misdiagnose either direction and the fix doesn't merely fail to help. It accelerates the decline, because a company convinced its execution is the problem responds by gripping the failing plan tighter.

The test for telling the two apart is simple to state and harder to run honestly: would a completely different team, handed your exact plan, also fail? If yes, the plan is the problem - a strategy failure, and no amount of grit fixes it. Would a sharper team take your current plan and win with it? If yes, the plan was fine and the problem is how it's being run - an execution failure, fixed with discipline and talent, not a new direction. The test works because it separates the quality of an idea from the quality of the people currently attempting it, a distinction most internal post-mortems never make. They ask what went wrong and land on whoever's in the room, when the real question is which variable - the plan, or the execution of it - would have to change to produce a different result.

Lego's own instinct was the disease: growth had stalled, so the board's answer was to become something other than a toy brick company

Lego's leadership had watched growth stall through the late 1990s, and their read at the time was that the brick itself had become too small a business to bet the company on. So they expanded outward: parks, apparel, video games, television, and a parts catalog that nearly doubled in the name of creative range.³ Every one of those bets was, in isolation, a defensible growth idea. Together, they amounted to a company betting that its problem was a shortage of ambition. When the losses arrived - a 2003 loss in the range of $300 million, with 2004 projected as high as $400 million, by which point the business was, in one contemporary account, 'virtually out of cash'² - the instinct inside the building wasn't to question the direction. It was to read the losses as proof the diversification hadn't gone far enough yet.

What actually happened next was that Jorgen Vig Knudstorp, then a strategy executive inside the company, effectively ran the test above and told the board something an internal team rarely has the standing to say out loud.

He became CEO the following year - the first person to run Lego from outside the founding Kristiansen family¹ - precisely because being an outsider gave him the distance to call the sprawl itself the failure, not the effort behind it. Run the swap test on Lego's actual 2003 strategy: hand a sharper team the same theme parks, the same apparel line, the same multiplying parts catalog, and they still run out of cash. That's a verdict on the plan, not the people executing it - and it's the verdict that gave Knudstorp the license to do something that looks, from a growth-first vantage point, like giving up.

A correct diagnosis still has to be sequenced: survive, then stabilize, then earn the right to grow again

Knowing the plan was the problem didn't tell Knudstorp what to fix first. A correct diagnosis still has to be sequenced, because a company this close to the edge can't repair everything at once - and repairing things in the wrong order can finish what the original strategy started.

Run the test on your own numbers: the same sequence, generalized past Lego

The test travels past Lego. It doesn't need a company this famous or a memo this dramatic to apply - it needs the same honesty about which variable, plan or execution, would actually have to change.

The trap that makes misdiagnosis dangerous: the instinct that caused the crisis is usually the instinct you reach for again

Here's what makes the distinction dangerous rather than merely interesting: the instinct that caused the crisis is usually the exact instinct a panicking company reaches for to solve it. Lego's leadership didn't diversify because they were careless; they diversified because growth had stalled and diversifying looked like the responsible, ambitious answer. When that diversification started failing too, the natural read inside the building wasn't 'we picked the wrong direction' - it was 'we haven't committed hard enough to this direction yet.' That is the misdiagnosis in its most dangerous form: treating a strategy failure as an execution problem, and answering it by executing the bad strategy with more conviction. It is always available as an explanation, it always feels like leadership, and it is frequently exactly backward. A company that diagnoses strategy as execution doesn't just fail to fix itself. It burns the cash and the trust it would have needed to survive the correct fix, once someone finally names it.

There's a time limit on all of this, too. A correct diagnosis arrived at too late doesn't help, because the resources needed to act on it - cash, trust, a board's patience - are exactly what a wrong diagnosis spends first. Lego's numbers in 2003 were bad enough that the company was, by its own account, close to running out of runway entirely² - the diagnosis and the sequencing above only worked because they arrived while there was still something left to sequence. Waiting for certainty before naming the problem is its own kind of misdiagnosis.

The honest complication is that the lesson isn't 'expansion is always the disease.' Lego's turnaround wasn't a permanent renunciation of growth beyond the brick - it was a sequencing correction. Once the core was disciplined again, Lego went back into exactly the kind of adjacency that had nearly killed it: film, video games, entertainment partnerships, most visibly a 2014 movie that grossed $468 million worldwide.⁶ Diversification wasn't the strategy failure. Diversifying while the core was undisciplined and undefended was. A team running that same expansion plan today, from a Lego with pricing power, supply chain control, and a profitable core behind it, gets a different verdict on the identical test.

Lego's turnaround is remembered as a story about focus, and it was. But the harder move happened earlier and more privately, in the moment someone inside the company had the standing to say that the strategy, not the effort behind it, was what had nearly killed it. That's the diagnosis most declining companies never reach, because admitting the plan is wrong feels like admitting the last several years were wasted, while doubling down on execution feels like leadership. The test doesn't care which one feels better. It only asks which one is true: swap the team and the plan still fails, or swap nothing but the talent and it wins. Answer that honestly before you fix anything - or the fix, however hard everyone works at it, will be aimed at the wrong disease.